INS and diabetes mellitus: MODY patients typically exhibit hyperglycaemia but are not insulin resistant, and thus the GENA348 mouse represents a novel model to investigate early changes to mitochondrial function and importantly, new insights into the early progression of other more pathogenic forms of diabetes.